Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 26, 1996 - Issue 9
Submit an article Journal homepage
604
Views
209
CrossRef citations to date
0
Altmetric
Original Article

Interspecies scaling: predicting clearance of drugs in humans. Three different approaches

I. Mahmood Division of Pharmaceutical Evaluation I. Office of the Clinical Pharmacology and Biopharmaceutics (I.M.) & Neuropharmacological Drug Products (J.D.B.). Food & Drug Administration. Woodmont Office Center II, 1451 Rockville Pike, Rockville, MD, 20852, USA
&
J. D. Balian Division of Pharmaceutical Evaluation I. Office of the Clinical Pharmacology and Biopharmaceutics (I.M.) & Neuropharmacological Drug Products (J.D.B.). Food & Drug Administration. Woodmont Office Center II, 1451 Rockville Pike, Rockville, MD, 20852, USA
Pages 887-895 | Received 18 Jan 1996, Published online: 27 Aug 2009

Citations (209)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (30)

Li Di. (2023) Recent advances in measurement of metabolic clearance, metabolite profile and reaction phenotyping of low clearance compounds. Expert Opinion on Drug Discovery 18:11, pages 1209-1219.
Read now
Pan-Pan Ye, Yi Zheng, Bin Du, Xi-Ting Liu, Bo-Hao Tang, Min Kan, Yue Zhou, Guo-Xiang Hao, Xin Huang, Le-Qun Su, Wen-Qi Wang, Feng Yu & Wei Zhao. (2020) First dose in neonates: pharmacokinetic bridging study from juvenile mice to neonates for drugs metabolized by CYP3A. Xenobiotica 50:11, pages 1275-1284.
Read now
Keiichi Morita, Motohiro Kato, Toshiyuki Kudo & Kiyomi Ito. (2020) In vitro–in vivo extrapolation of metabolic clearance using human liver microsomes: factors showing variability and their normalization. Xenobiotica 50:9, pages 1064-1075.
Read now
Adam J. Lucas, Joanne L. Sproston, Patrick Barton & Robert J. Riley. (2019) Estimating human ADME properties, pharmacokinetic parameters and likely clinical dose in drug discovery. Expert Opinion on Drug Discovery 14:12, pages 1313-1327.
Read now
Bianca M. Liederer, Jonathan Cheong, Kang-Jye Chou, Peter S. Dragovich, Hoa Le, Xiaorong Liang, Justin Ly, Sophie Mukadam, Jason Oeh, Deepak Sampath, Leslie Wang & Susan Wong. (2019) Preclinical assessment of the ADME, efficacy and drug-drug interaction potential of a novel NAMPT inhibitor. Xenobiotica 49:9, pages 1063-1077.
Read now
Weon Sup Lee, Sang Ryeol Shim, Seon Young Lee, Jin San Yoo & Sung Kweon Cho. (2018) Preclinical pharmacokinetics, interspecies scaling, and pharmacokinetics of a Phase I clinical trial of TTAC-0001, a fully human monoclonal antibody against vascular endothelial growth factor 2. Drug Design, Development and Therapy 12, pages 495-504.
Read now
Iftekhar Mahmood. (2018) Misconceptions and issues regarding allometric scaling during the drug development process. Expert Opinion on Drug Metabolism & Toxicology 14:8, pages 843-854.
Read now
Mary E. Spilker, Heekyung Chung, Ravi Visswanathan, Shubha Bagrodia, Steven Gernhardt, Valeria R. Fantin & Lesley G. Ellies. (2017) Leveraging model-based study designs and serial micro-sampling techniques to understand the oral pharmacokinetics of the potent LTB4 inhibitor, CP-105696, for mouse pharmacology studies. Xenobiotica 47:7, pages 600-606.
Read now
Sherri A. Smith, Sandra Gagnon & Nigel J. Waters. (2017) Mechanistic investigations into the species differences in pinometostat clearance: impact of binding to alpha-1-acid glycoprotein and permeability-limited hepatic uptake. Xenobiotica 47:3, pages 185-193.
Read now
Qingbiao Huang & Jim E Riviere. (2014) The application of allometric scaling principles to predict pharmacokinetic parameters across species. Expert Opinion on Drug Metabolism & Toxicology 10:9, pages 1241-1253.
Read now
Elliot Offman & Andrea N. Edginton. (2013) Contrasting toxicokinetic evaluations and interspecies pharmacokinetic scaling approaches for small molecules and biologics: applicability to biosimilar development. Xenobiotica 43:6, pages 561-569.
Read now
Kotaro Ogawa, Motohiro Kato, Takao Houjo & Masaki Ishigai. (2013) A new approach to predicting human hepatic clearance of CYP3A4 substrates using monkey pharmacokinetic data. Xenobiotica 43:5, pages 468-478.
Read now
Iftekhar Mahmood. (2013) Prediction of drug concentration-time profiles of therapeutic proteins in humans from animals. Xenobiotica 43:2, pages 153-160.
Read now
Iftekhar Mahmood & Kosalaram Goteti. (2012) Prediction of drug concentration-time data in humans from animals: a comparison of three methods. Xenobiotica 42:8, pages 756-765.
Read now
Simon Taylor, James R. J. Gray, Robert Willis, Nigel Deeks, Andrea Haynes, Colin Campbell, Pam Gaskin, Karen Leavens, Emmanuel Demont, Simon Dowell, Jenni Cryan, Mary Morse, Aarti Patel, Helen Garden & Jason Witherington. (2012) The utility of pharmacokinetic–pharmacodynamic modeling in the discovery and optimization of selective S1P1 agonists. Xenobiotica 42:7, pages 671-686.
Read now
Luc Bijnens, An Van den Bergh, Vikash Sinha, Helena Geys, Geert Molenberghs, Tobias Verbeke, Adetayo Kasim, Roel Straetemans, Filip De Ridder & Claire Balmain-Mackie. (2012) A Meta-Analytical Framework to Include Historical Data in Allometric Scaling. Statistics in Biopharmaceutical Research 4:2, pages 205-215.
Read now
Laurent Salphati, Jodie Pang, Emile G. Plise, Bilin Chou, Jason S. Halladay, Alan G. Olivero, Patrick J. Rudewicz, Qingping Tian, Susan Wong & Xiaolin Zhang. (2011) Preclinical pharmacokinetics of the novel PI3K inhibitor GDC-0941 and prediction of its pharmacokinetics and efficacy in human. Xenobiotica 41:12, pages 1088-1099.
Read now
Yeamin Huh, David E Smith & Meihau Rose Feng. (2011) Interspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugs. Xenobiotica 41:11, pages 972-987.
Read now
Liyue Huang, Xuhai Be, Loren Berry, Earl Moore, Brett Janosky, Mary Wells, Wei-Jian Pan, Zhiyang Zhao & Min-Hwa Jasmine Lin. (2011) In vitro and in vivo pharmacokinetic characterizations of AMG 900, an orally bioavailable small molecule inhibitor of aurora kinases. Xenobiotica 41:5, pages 400-408.
Read now
Bianca M. Liederer, Leonid M. Berezhkovskiy, Brian J. Dean, Vikki Dinkel, Jing Peng, Mark Merchant, Emile G. Plise, Harvey Wong & Xingrong Liu. (2011) Preclinical absorption, distribution, metabolism, excretion, and pharmacokinetic–pharmacodynamic modelling of N-(4-(3-((3S,4R)-1-ethyl-3-fluoropiperidine-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-4-yloxy)-3-fluorophenyl)-2-(4-fluorophenyl)-3-oxo-2,3-dihydropyridazine-4-carboxamide, a novel MET kinase inhibitor. Xenobiotica 41:4, pages 327-339.
Read now
Rong Deng, Suhasini Iyer, Frank-Peter Theil, Deborah L. Mortensen, Paul J. Fielder & Saileta Prabhu. (2011) Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data. mAbs 3:1, pages 61-66.
Read now
Jeng-Pyng Shaw & Sarah Jaw-Tsai. (2011) An interspecies extrapolation of the pharmacokinetics of telavancin, a rapidly bactericidal, concentration-dependent antibiotic. Xenobiotica 41:1, pages 82-89.
Read now
Edna F. Choo, Marcia Belvin, Jocelyn Chan, Klaus Hoeflich, Christine Orr, Kirk Robarge, Xiaoye Yang, Mark Zak & Jason Boggs. (2010) Preclinical disposition and pharmacokinetics-pharmacodynamic modeling of biomarker response and tumour growth inhibition in xenograft mouse models of G-573, a MEK inhibitor. Xenobiotica 40:11, pages 751-762.
Read now
E. F. Choo, J. P. Driscoll, J. Feng, B. Liederer, E. Plise, N. Randolph, Y. Shin, S. Wong & Y. Ran. (2009) Disposition of GDC-0879, a B-RAF kinase inhibitor in preclinical species. Xenobiotica 39:9, pages 700-709.
Read now
Pascal Espié, Dominique Tytgat, Maria-Laura Sargentini-Maier, Italo Poggesi & Jean-Baptiste Watelet. (2009) Physiologically based pharmacokinetics (PBPK). Drug Metabolism Reviews 41:3, pages 391-407.
Read now
P. J. Lowe, Y. Hijazi, O. Luttringer, H. Yin, R. Sarangapani & D. Howard. (2007) On the anticipation of the human dose in first-in-man trials from preclinical and prior clinical information in early drug development. Xenobiotica 37:10-11, pages 1331-1354.
Read now
M. R. Shiran, N. J. Proctor, E. M. Howgate, K. Rowland-Yeo, G. T. Tucker & A. Rostami-Hodjegan. (2006) Prediction of metabolic drug clearance in humans: extrapolation allometric scaling. Xenobiotica 36:7, pages 567-580.
Read now
A. S. Kalgutkar, E. Choo, T. J. Taylor & A. Marfat. (2004) Disposition of CP-671, 305, a selective phosphodiesterase 4 inhibitor in preclinical species. Xenobiotica 34:8, pages 755-770.
Read now
T. Prueksaritanont, C. Fernandez-Metzler, Y. Meng, A. Barrish, W. Halczenko, S. B. Rodan, J. H. Hutchinson, M. E. Duggan & J. H. Lin. (2004) Disposition of a novel and potent αvβ3 antagonist in animals, and extrapolation to man. Xenobiotica 34:1, pages 103-115.
Read now
J. Brian Houston & Aleksandra Galetin. (2003) Progress Towards Prediction of Human Pharmacokinetic Parameters from In Vitro Technologies. Drug Metabolism Reviews 35:4, pages 393-415.
Read now

Articles from other publishers (179)

Christopher E. Keefer, George Chang, Li Di, Nathaniel A. Woody, David A. Tess, Sarah M. Osgood, Brendon Kapinos, Jill Racich, Anthony A. Carlo, Amanda Balesano, Nicholas Ferguson, Christine Orozco, Larisa Zueva & Lina Luo. (2023) The Comparison of Machine Learning and Mechanistic In Vitro–In Vivo Extrapolation Models for the Prediction of Human Intrinsic Clearance. Molecular Pharmaceutics 20:11, pages 5616-5630.
Crossref
Akihito Ogasawara, Kei Ogawa, Ryosuke Ide, Yuka Ikenaga, Chie Fukunaga, Satoshi Nakayama & Minoru Tsuda. (2023) Results from a first-in-human study of dersimelagon, an investigational oral selective MC1R agonist. European Journal of Clinical Pharmacology 79:6, pages 801-813.
Crossref
Christina Vasalou, Joanna Harding, Rhys D. O. Jones, Niresh Hariparsad & Dermot F. McGinnity. (2023) Interspecies evaluation of a physiologically based pharmacokinetic model to predict the biodistribution dynamics of dendritic nanoparticles. PLOS ONE 18:5, pages e0285798.
Crossref
Tridib Chaira, Chandru Subramani & Tarani Kanta Barman. (2023) ADME, Pharmacokinetic Scaling, Pharmacodynamic and Prediction of Human Dose and Regimen of Novel Antiviral Drugs. Pharmaceutics 15:4, pages 1212.
Crossref
Sohyun Park, Youn Woo Lee, Jaeseong Oh, Su Jin Kim, Sukmook Lee & Ho‐Young Lee. (2022) Pharmacokinetic evaluation of radiolabeled intraocular anti‐CLEC14a antibody in preclinical animal species and application in humans . Clinical and Translational Science 15:12, pages 2938-2946.
Crossref
Philip G. Humphreys, Niall A. Anderson, Paul Bamborough, Andrew BaxterChun-wa Chung, Rosa CooksonPeter D. CraggsToryn Dalton, Julie C. L. Fournier, Laurie J. GordonHeather F. Gray, Matthew W. Gray, Richard GregoryDavid J. HirstCraig Jamieson, Katherine L. Jones, Hripsimee KessedjianDavid LugoGrant McGonagleVipulkumar K. PatelChristopher PattenDarren L. PooleRab K. PrinjhaCesar Ramirez-MolinaInmaculada RiojaGail SealKayleigh A. J. StaffordRishi R. Shah, Daniel TapeNatalie H. TheodoulouLaura TomlinsonSabri UkuserIan D. WallNatalie WellawayGemma White. (2022) Identification and Optimization of a Ligand-Efficient Benzoazepinone Bromodomain and Extra Terminal (BET) Family Acetyl-Lysine Mimetic into the Oral Candidate Quality Molecule I-BET432. Journal of Medicinal Chemistry 65:22, pages 15174-15207.
Crossref
Tord Inghardt, Thomas Antonsson, Cecilia Ericsson, Daniel Hovdal, Petra Johannesson, Carina Johansson, Ulrik Jurva, Johan Kajanus, Bengt Kull, Erik Michaëlsson, Anna Pettersen, Tove Sjögren, Henrik Sörensen, Kristina Westerlund & Eva-Lotte Lindstedt. (2022) Discovery of AZD4831, a Mechanism-Based Irreversible Inhibitor of Myeloperoxidase, As a Potential Treatment for Heart Failure with Preserved Ejection Fraction. Journal of Medicinal Chemistry 65:17, pages 11485-11496.
Crossref
Yan Weng, Kari R. Fonseca, Yi-an Bi, Sumathy Mathialagan, Keith Riccardi, Elaine Tseng, Andrew J. Bessire, Mathew A. Cerny, David A. Tess, A. David Rodrigues, Amit S. Kalgutkar, John Litchfield, Li Di & Manthena V. S. Varma. (2022) Transporter-Enzyme Interplay in the Pharmacokinetics of PF-06835919, a First-In-Class Ketohexokinase Inhibitor for Metabolic Disorders and Nonalcoholic Fatty Liver Disease. Drug Metabolism and Disposition 50:9, pages 1312-1321.
Crossref
Amy Q. Wang, Natalie R. Hagen, Elias C. Padilha, Mengbi Yang, Pranav Shah, Catherine Z. Chen, Wenwei Huang, Pramod Terse, Philip Sanderson, Wei Zheng & Xin Xu. (2022) Preclinical Pharmacokinetics and In Vitro Properties of GS-441524, a Potential Oral Drug Candidate for COVID-19 Treatment. Frontiers in Pharmacology 13.
Crossref
A. Young J. Park, Dat Q. Tran, Justin B. Schaal, Mengxi Wang, Michael E. Selsted & Paul M. Beringer. (2022) Preclinical Pharmacokinetics and Safety of Intravenous RTD-1. Antimicrobial Agents and Chemotherapy 66:3.
Crossref
Xin Li, Zhigao Zhang, Yang Chen, Bin Wang, Guimei Yang, Xiangbin Xu, Baihui Yechao, Dongdong Bai, Binqiang Feng, Yuchang Mao, Jun Feng, Chang Bai, Feng He & Weikang Tao. (2022) Discovery of SHR5133, a Highly Potent and Novel HBV Capsid Assembly Modulator. ACS Medicinal Chemistry Letters 13:3, pages 507-512.
Crossref
Kosuke Yoshida, Yuki Doi, Norihiko Iwazaki, Hidenori Yasuhara, Yuka Ikenaga, Hidetoshi Shimizu, Tomohisa Nakada, Tomoko Watanabe, Chise Tateno, Seigo Sanoh & Yaichiro Kotake. (2021) Prediction of human pharmacokinetics for low‐clearance compounds using pharmacokinetic data from chimeric mice with humanized livers. Clinical and Translational Science 15:1, pages 79-91.
Crossref
Karen-Margrethe Pedersen, Anna Katrina Jógvansdóttir Gradel, Trine Pagh Ludvigsen, Berit Østergaard Christoffersen, Caroline Amalie Fuglsang-Damgaard, Kristian Moss Bendtsen, Suzi Høgh Madsen, Valentina Manfé & Hanne Hoffmann Frølund Refsgaard. (2022) Optimization of pig models for translation of subcutaneous pharmacokinetics of therapeutic proteins: Liraglutide, insulin aspart and insulin detemir. Translational Research 239, pages 71-84.
Crossref
Lionel Trottet. 2021. Fundamentals of Drug Delivery. Fundamentals of Drug Delivery 53 71 .
Renu Singh, Maria Moreno & Danica Stanimirovic. (2021) Comparison of Various Approaches to Translate Non-Linear Pharmacokinetics of Monoclonal Antibodies from Cynomolgus Monkey to Human. European Journal of Drug Metabolism and Pharmacokinetics 46:4, pages 555-567.
Crossref
Tomás Sou, Jon Hansen, Edgars Liepinsh, Maria Backlund, Onur Ercan, Solveiga Grinberga, Sha Cao, Paraskevi Giachou, Anna Petersson, Magdalena Tomczak, Malgorzata Urbas, Dorota Zabicka, Carina Vingsbo Lundberg, Diarmaid Hughes, Sven N. Hobbie & Lena E. Friberg. (2020) Model‐Informed Drug Development for Antimicrobials: Translational PK and PK/PD Modeling to Predict an Efficacious Human Dose for Apramycin. Clinical Pharmacology & Therapeutics 109:4, pages 1063-1073.
Crossref
David A. Tess, Heather Eng, Amit S. Kalgutkar, John Litchfield, David J. Edmonds, David A. Griffith & Manthena V. S. Varma. (2020) Predicting the Human Hepatic Clearance of Acidic and Zwitterionic Drugs. Journal of Medicinal Chemistry 63:20, pages 11831-11844.
Crossref
Ramakrishna Nirogi, Gopinadh Bhyrapuneni, Nageswara Rao Muddana, Arunkumar Manoharan, Anil K Shinde, Abdul Rasheed Mohammed, Nagasurya Prakash Padala, Devender Reddy Ajjala, Ramkumar Subramanian & Veera Raghava Chowdary Palacharla. (2020) Absorption, distribution, metabolism, excretion (ADME), drug-drug interaction potential and prediction of human pharmacokinetics of SUVN-G3031, a novel histamine 3 receptor (H3R) inverse agonist in clinical development for the treatment of narcolepsy. European Journal of Pharmaceutical Sciences 152, pages 105425.
Crossref
Simone Pollo & Augusto Vitale. (2020) Evaluating the Scientific Uses of Animals: A Virtue-Consequentialist Approach for Harm/Benefit Analyses. Journal of Applied Animal Ethics Research 2:2, pages 193-215.
Crossref
Katja Jansen, Carla Pou Casellas, Lucianne Groenink, Kimberley E. Wever & Rosalinde Masereeuw. (2020) Humans are animals, but are animals human enough? A systematic review and meta-analysis on interspecies differences in renal drug clearance. Drug Discovery Today 25:4, pages 706-717.
Crossref
Elias C. Padilha, Pranav Shah, Amy Q. Wang, Marc D. Singleton, Emma A. Hughes, Dandan Li, Kelly A. Rice, Kylie M. Konrath, Samarjit Patnaik, Juan Marugan, Udo Rudloff & Xin Xu. (2020) Metabolism and pharmacokinetics characterization of metarrestin in multiple species. Cancer Chemotherapy and Pharmacology 85:4, pages 805-816.
Crossref
Christopher R. Wellaway, Dominique AmansPaul Bamborough, Heather BarnettRino A. BitJack A. BrownNeil R. Carlson, Chun-wa ChungAnthony W. J. CooperPeter D. CraggsRobert P. DavisTony W. DeanJohn P. EvansLaurie GordonIsobel L. HaradaDavid J. Hirst, Philip G. Humphreys, Katherine L. JonesAntonia J. LewisMatthew J. LindonDave LugoMahnoor MahmoodScott McClearyPatricia Medeiros, Darren J. MitchellMichael O’SullivanArmelle Le GallVipulkumar K. PatelChris PattenDarren L. PooleRishi R. Shah, Jane E. SmithKayleigh A. J. StaffordPamela J. ThomasMythily VimalIan D. WallRobert J. WatsonNatalie WellawayGang Yao & Rab K. Prinjha. (2020) Discovery of a Bromodomain and Extraterminal Inhibitor with a Low Predicted Human Dose through Synergistic Use of Encoded Library Technology and Fragment Screening. Journal of Medicinal Chemistry 63:2, pages 714-746.
Crossref
Véronique Gayrard, Marlène Z. Lacroix, Clémence A. Gély, Flore C. Grandin, Roger Léandri, Michèle Bouchard, Béatrice Roques, Pierre-Louis Toutain & Nicole Picard-Hagen. (2020) Toxicokinetics of bisphenol S in rats for predicting human bisphenol S clearance from allometric scaling. Toxicology and Applied Pharmacology 386, pages 114845.
Crossref
Robert S. Jones, Justin Q. Ly & Jae H. Chang. 2020. Identification and Quantification of Drugs, Metabolites, Drug Metabolizing Enzymes, and Transporters. Identification and Quantification of Drugs, Metabolites, Drug Metabolizing Enzymes, and Transporters 555 594 .
Ravi Kumar Jairam, Sadanand Rangnathrao Mallurwar, Suresh P. Sulochana, Devaraj V. Chandrasekhar, Umesh Todmal, Ravi Kanth Bhamidipati, Wolfgang Richter, Nuggehally R. Srinivas & Ramesh Mullangi. (2019) Prediction of Human Pharmacokinetics of Fomepizole from Preclinical Species Pharmacokinetics Based on Normalizing Time Course Profiles. AAPS PharmSciTech 20:6.
Crossref
Yi Gu, Yang Sai, Jian Wang, Meijing Yu, Guanglin Wang, Li Zhang, Hongcan Ren, Shiming Fan, Yongxin Ren, Weiguo Qing & Weiguo Su. (2019) Preclinical pharmacokinetics, disposition, and translational pharmacokinetic/pharmacodynamic modeling of savolitinib, a novel selective cMet inhibitor. European Journal of Pharmaceutical Sciences 136, pages 104938.
Crossref
Go-Wun Choi, Yong-Bok Lee & Hea-Young Cho. (2019) Interpretation of Non-Clinical Data for Prediction of Human Pharmacokinetic Parameters: In Vitro-In Vivo Extrapolation and Allometric Scaling. Pharmaceutics 11:4, pages 168.
Crossref
Jie Shen, Brandon Swift, Richard Mamelok, Samuel Pine, John Sinclair & Mayssa Attar. (2018) Design and Conduct Considerations for First‐in‐Human Trials. Clinical and Translational Science 12:1, pages 6-19.
Crossref
Jaydeep Sinha, Hesham S. Al-Sallami & Stephen B. Duffull. (2018) Choosing the Allometric Exponent in Covariate Model Building. Clinical Pharmacokinetics 58:1, pages 89-100.
Crossref
Huadong Tang & Michael Mayersohn. (2018) Porcine Prediction of Pharmacokinetic Parameters in People: A Pig in a Poke?. Drug Metabolism and Disposition 46:11, pages 1712-1724.
Crossref
Ponnayyan Sulochana Suresh, Ravi Kumar Jairam, Devaraj V. Chandrasekhar, Anera Balakrishna Vinod, Rakesh A. Hiremath, Anusha Raj, Mohd Zainuddin, Ravi Kanth Bhamidipati & Ramesh Mullangi. (2018) Prediction of Human Pharmacokinetics of Ulixertinib, a Novel ERK1/2 Inhibitor from Mice, Rats, and Dogs Pharmacokinetics. European Journal of Drug Metabolism and Pharmacokinetics 43:4, pages 453-460.
Crossref
Yuwei Deng, Li Hu, Wei Qiang, Zeneng Cheng, Lei Wang & Xiaoxia Wang. (2018) TNF-α level affects etanercept clearance: TNF-α concentration as a new correction factor of allometric scaling to predict individual etanercept clearances in patients with ankylosing spondylitis. Clinical and Experimental Pharmacology and Physiology 45:7, pages 643-651.
Crossref
Kana Horiuchi, Shuichi Ohnishi, Takanobu Matsuzaki, Satoko Funaki, Ayahisa Watanabe, Tohru Mizutare, Sayaka Matsumoto, Ken-ichi Nezasa & Hiroshi Hasegawa. (2018) Improved Human Pharmacokinetic Prediction of Hepatically Metabolized Drugs With Species-Specific Systemic Clearance. Journal of Pharmaceutical Sciences 107:5, pages 1443-1453.
Crossref
Ankur Sharma, Doris Mangiaracina Benbrook & Sukyung Woo. (2018) Pharmacokinetics and interspecies scaling of a novel, orally-bioavailable anti-cancer drug, SHetA2. PLOS ONE 13:4, pages e0194046.
Crossref
Takuya Ebihara, Mitsuhiro Nishihara, Junzo Takahashi, Fumihiro Jinno & Yoshihiko Tagawa. (2018) Differences in nonclinical pharmacokinetics between species and prediction of human pharmacokinetics of TAK-272 (SCO-272), a novel orally active renin inhibitor. Biopharmaceutics & Drug Disposition 39:3, pages 175-183.
Crossref
Christa C. Chrovian, Akinola Soyode-Johnson, Alexander A. Peterson, Christine F. Gelin, Xiaohu Deng, Curt A. Dvorak, Nicholas I. Carruthers, Brian Lord, Ian Fraser, Leah Aluisio, Kevin J. Coe, Brian Scott, Tatiana Koudriakova, Freddy Schoetens, Kia Sepassi, David J. Gallacher, Anindya Bhattacharya & Michael A. Letavic. (2017) A Dipolar Cycloaddition Reaction To Access 6-Methyl-4,5,6,7-tetrahydro-1 H -[1,2,3]triazolo[4,5- c ]pyridines Enables the Discovery Synthesis and Preclinical Profiling of a P2X7 Antagonist Clinical Candidate . Journal of Medicinal Chemistry 61:1, pages 207-223.
Crossref
Zheng Lu, Rüdiger Kaspera, Yoichi Naritomi & Tianli Wang. 2018. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology 1 11 .
Keumhan Noh & ψ Wonku Kang. (2017) Calculation of a First-In-Man Dose of 7- O -Succinyl Macrolactin A Based on Allometric Scaling of Data from Mice, Rats, and Dogs . Biomolecules & Therapeutics 25:6, pages 648-658.
Crossref
James R. Gosset, Kevin Beaumont, Tomomi Matsuura, Wendy Winchester, Neil Attkins, Sophie Glatt, Ian Lightbown, Kristina Ulrich, Sonia Roberts, Jolie Harris, Emir Mesic, Tamara van Steeg, Diana Hijdra & Piet H. van der Graaf. (2017) A cross-species translational pharmacokinetic-pharmacodynamic evaluation of core body temperature reduction by the TRPM8 blocker PF-05105679. European Journal of Pharmaceutical Sciences 109, pages S161-S167.
Crossref
Chuenlei Parng, Victoria Markiewicz, Jianqing Chen, Beth Leary, Nicole Duriga, Lisa Dyleski, Teresa Caiazzo, Michael Bolt, Alison Joyce, Boris Gorovits, Debra D. Pittman & Robert Webster. (2017) Preclinical Pharmacokinetics, Pharmacodynamics, Tissue Distribution, and Interspecies Scaling of Recombinant Human Coagulation Factor Xa I16L. Journal of Pharmaceutical Sciences 106:8, pages 2136-2143.
Crossref
Elliot Offman & Andrea N. Edginton. (2016) Pharmacokinetic Time Course Scaling of a Subcutaneously Administered Pegylated Peptide Conjugate for a First-in-Human Investigation. European Journal of Drug Metabolism and Pharmacokinetics 42:1, pages 69-78.
Crossref
Lionel Trottet & Howard Maibach, MDLionel Trottet & Howard Maibach. 2017. Dermal Drug Selection and Development. Dermal Drug Selection and Development 115 131 .
Iftekhar Mahmood, Anna Cheng, Edward Brauer & Rita Humeniuk. (2015) Prediction of Antimalarial Drug Clearance in Children: A Comparison of Three Different Interspecies Scaling Methods. European Journal of Drug Metabolism and Pharmacokinetics 41:6, pages 767-775.
Crossref
Hannah M. Jones, Richard P. Butt, Rob W. Webster, Ian Gurrell, Pawel Dzygiel, Neil Flanagan, Daniela Fraier, Tanya Hay, Laura Else Iavarone, Jacquelynn Luckwell, Hannah Pearce, Alex Phipps, Jill Segelbacher, Bill Speed & Kevin Beaumont. (2016) Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium Channels. Clinical Pharmacokinetics 55:7, pages 875-887.
Crossref
Takashi Nakai, Nicholas R. Perl, Timothy C. Barden, Andrew Carvalho, Angelika Fretzen, Peter Germano, G-Yoon J. Im, Hong Jin, Charles Kim, Thomas W.-H. Lee, Kimberly Long, Joel Moore, Jason M. Rohde, Renee Sarno, Chrissie Segal, Erik O. Solberg, Jenny Tobin, Daniel P. Zimmer & Mark G. Currie. (2016) Discovery of IWP-051, a Novel Orally Bioavailable sGC Stimulator with Once-Daily Dosing Potential in Humans. ACS Medicinal Chemistry Letters 7:5, pages 465-469.
Crossref
Elliot Offman, Colin Phipps & Andrea N. Edginton. (2016) Population physiologically-based pharmacokinetic model incorporating lymphatic uptake for a subcutaneously administered pegylated peptide. In Silico Pharmacology 4:1.
Crossref
Lei Wang, Wei Qiang & Zeneng Cheng. (2016) Allometric Scaling of Therapeutic Monoclonal Antibodies Using Antigen Concentration as a Correction Factor: Application to the Human Clearance Prediction. Journal of Pharmaceutical Sciences 105:3, pages 1335-1340.
Crossref
Dennis A. Smith & Thomas A. Baillie. 2015. Attrition in the Pharmaceutical Industry. Attrition in the Pharmaceutical Industry 83 105 .
Wenkang Huang, Lv Geng, Rong Deng, Shaoyong Lu, Guangli Ma, Jianxiu Yu, Jian Zhang, Wei Liu, Tingjun Hou & Xuefeng Lu. (2015) Prediction of Human Clearance Based on Animal Data and Molecular Properties. Chemical Biology & Drug Design 86:5, pages 990-997.
Crossref
Jie Zhao, Yanguang Cao & William J. Jusko. (2015) Across-Species Scaling of Monoclonal Antibody Pharmacokinetics Using a Minimal PBPK Model. Pharmaceutical Research 32:10, pages 3269-3281.
Crossref
Tao Zhang, Tycho Heimbach, Wen Lin, Jin Zhang & Handan He. (2015) Prospective Predictions of Human Pharmacokinetics for Eighteen Compounds. Journal of Pharmaceutical Sciences 104:9, pages 2795-2806.
Crossref
Christoph Thiel, Sebastian Schneckener, Markus Krauss, Ahmed Ghallab, Ute Hofmann, Tobias Kanacher, Sebastian Zellmer, Rolf Gebhardt, Jan G. Hengstler & Lars Kuepfer. (2015) A Systematic Evaluation of the Use of Physiologically Based Pharmacokinetic Modeling for Cross-Species Extrapolation. Journal of Pharmaceutical Sciences 104:1, pages 191-206.
Crossref
Rao Mukkavilli, Jakir Pinjari, Bhavesh Patel, Shankar Sengottuvelan, Subodh Mondal, Ajit Gadekar, Manas Verma, Jignesh Patel, Lavanya Pothuri, Gopu Chandrashekar, Prabhakar Koiram, Tanukrishnan Harisudhan, Ansari Moinuddin, Delphine Launay, Nimish Vachharajani, Vikram Ramanathan & Denis Martin. (2014) In vitro metabolism, disposition, preclinical pharmacokinetics and prediction of human pharmacokinetics of DNDI-VL-2098, a potential oral treatment for Visceral Leishmaniasis. European Journal of Pharmaceutical Sciences 65, pages 147-155.
Crossref
Thomas. M. Bridges, Ryan D. Morrison, Frank W. Byers, Shuanghui Luo & J. Scott Daniels. (2014) Use of a novel rapid and resource‐efficient cassette dosing approach to determine the pharmacokinetics and CNS distribution of small molecule 7‐transmembrane receptor allosteric modulators in rat. Pharmacology Research & Perspectives 2:6.
Crossref
Wei Zhao, Chantal Le Guellec, Daniel K. BenjaminJr.Jr., William W. Hope, Thomas Bourgeois, Kevin M. Watt, Johannes N. van den Anker, Boris Matrot, Harri Saxen, Kalle Hoppu, Paolo Manzoni & Evelyne Jacqz-Aigrain. (2014) First Dose in Neonates: Are Juvenile Mice, Adults and In Vitro–In Silico Data Predictive of Neonatal Pharmacokinetics of Fluconazole. Clinical Pharmacokinetics 53:11, pages 1005-1018.
Crossref
S. M. D. K. Ganga Senarathna & Kevin T. Batty. (2014) Interspecies Allometric Scaling of Antimalarial Drugs and Potential Application to Pediatric Dosing. Antimicrobial Agents and Chemotherapy 58:10, pages 6068-6078.
Crossref
Tetsuya Mitsui, Takayuki Nemoto, Taiji Miyake, Shunsuke Nagao, Kotaro Ogawa, Motohiro Kato, Masaki Ishigai & Hideyuki Yamada. (2014) A Useful Model Capable of Predicting the Clearance of Cytochrome P450 3A4 (CYP3A4) Substrates in Humans: Validity of CYP3A4 Transgenic Mice Lacking Their Own Cyp3a Enzymes. Drug Metabolism and Disposition 42:9, pages 1540-1547.
Crossref
Yi Gu, Jian Wang, Ke Li, Li Zhang, Hongcan Ren, Lixia Guo, Yang Sai, Weihan Zhang & Weiguo Su. (2014) Preclinical pharmacokinetics and disposition of a novel selective VEGFR inhibitor Fruquintinib (HMPL-013) and the prediction of its human pharmacokinetics. Cancer Chemotherapy and Pharmacology 74:1, pages 95-115.
Crossref
Iftekhar Mahmood & Harold Boxenbaum. (2014) Vertical allometry: Fact or fiction?. Regulatory Toxicology and Pharmacology 68:3, pages 468-474.
Crossref
Kevin Beaumont, James R. Gosset & Chris E. Keefer. 2014. Predictive ADMET. Predictive ADMET 291 318 .
I. Mahmood. (2013) Designing first‐in‐human dose of coagulation factors: application of pharmacokinetic allometric scaling. Haemophilia 20:1, pages 32-38.
Crossref
Brian R. Moyer. 2014. Pharmaco-Imaging in Drug and Biologics Development. Pharmaco-Imaging in Drug and Biologics Development 113 131 .
Adams Amantana, Yali Chen, Shanthakumar R. Tyavanagimatt, Kevin F. Jones, Robert Jordan, Jarasvech Chinsangaram, Tove′ C. Bolken, Janet M. Leeds & Dennis E. Hruby. (2013) Pharmacokinetics and Interspecies Allometric Scaling of ST-246, an Oral Antiviral Therapeutic for Treatment of Orthopoxvirus Infection. PLoS ONE 8:4, pages e61514.
Crossref
J. P. Wikswo, F. E. Block, D. E. Cliffel, C. R. Goodwin, C. C. Marasco, D. A. Markov, D. L. McLean, J. A. McLean, J. R. McKenzie, R. S. Reiserer, P. C. Samson, D. K. Schaffer, K. T. Seale & S. D. Sherrod. (2013) Engineering Challenges for Instrumenting and Controlling Integrated Organ-on-Chip Systems. IEEE Transactions on Biomedical Engineering 60:3, pages 682-690.
Crossref
Ting Chen, Donald E. Mager & Leonid Kagan. (2012) Interspecies Modeling and Prediction of Human Exenatide Pharmacokinetics. Pharmaceutical Research 30:3, pages 751-760.
Crossref
Ghada F. Ahmed, Richard C. Brundage, Susan E. Marino, James C. Cloyd, Ilo E. Leppik, Page B. Pennell, R. Eugene Ramsay & Angela K. Birnbaum. (2013) Population Pharmacokinetics of Unbound and Total Drug Concentrations Following Intravenously Administered Carbamazepine in Elderly and Younger Adult Patients With Epilepsy. The Journal of Clinical Pharmacology 53:3, pages 276-284.
Crossref
Hiroyuki Sayama, Hiroshi Komura & Motohiro Kogayu. (2013) Application of Hybrid Approach Based on Empirical and Physiological Concept for Predicting Pharmacokinetics in Humans—Usefulness of Exponent on Prospective Evaluation of Predictability. Drug Metabolism and Disposition 41:2, pages 498-507.
Crossref
M. Schrag & K. Regal. 2013. A Comprehensive Guide to Toxicology in Nonclinical Drug Development. A Comprehensive Guide to Toxicology in Nonclinical Drug Development 69 106 .
Michael Schrag & Kelly Regal. 2013. A Comprehensive Guide to Toxicology in Preclinical Drug Development. A Comprehensive Guide to Toxicology in Preclinical Drug Development 31 68 .
J. Brian Houston, Karen Rowland-Yeo & Ugo Zanelli. (2012) Evaluation of the novel in vitro systems for hepatic drug clearance and assessment of their predictive utility. Toxicology in Vitro 26:8, pages 1265-1271.
Crossref
Alexander V. LyubimovKevin Beaumont. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions 1 26 .
Alexander V. LyubimovHiroshi Komura & Masahiro Iwaki. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions 1 41 .
Laurent Salphati, Jodie Pang, Emile G. Plise, Leslie B. Lee, Alan G. Olivero, Wei Wei Prior, Deepak Sampath, Susan Wong & Xiaolin Zhang. (2012) Preclinical Assessment of the Absorption and Disposition of the Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor GDC-0980 and Prediction of Its Pharmacokinetics and Efficacy in Human. Drug Metabolism and Disposition 40:9, pages 1785-1796.
Crossref
Lian Zhou, Randy C. Dockens, Peggy Liu-Kreyche, Scott J. Grossman & Ramaswamy A. Iyer. (2012) In Vitro and In Vivo Metabolism and Pharmacokinetics of BMS-562086, a Potent and Orally Bioavailable Corticotropin-Releasing Factor-1 Receptor Antagonist. Drug Metabolism and Disposition 40:6, pages 1093-1103.
Crossref
John A. Flygare, Maureen Beresini, Nageshwar Budha, Helen Chan, Iris T. Chan, Sravanthi Cheeti, Frederick Cohen, Kurt Deshayes, Karl Doerner, S. Gail Eckhardt, Linda O. Elliott, Bainian Feng, Matthew C. Franklin, Stacy Frankovitz Reisner, Lewis Gazzard, Jason Halladay, Sarah G. Hymowitz, Hank La, Patricia LoRusso, Brigitte Maurer, Lesley Murray, Emile Plise, Clifford Quan, Jean-Philippe Stephan, Shin G. Young, Jeffrey Tom, Vickie Tsui, Joanne Um, Eugene Varfolomeev, Domagoj Vucic, Andrew J. Wagner, Heidi J. A. Wallweber, Lan Wang, Joseph Ware, Zhaoyang Wen, Harvey Wong, Jonathan M. Wong, Melisa Wong, Susan Wong, Ron Yu, Kerry Zobel & Wayne J. Fairbrother. (2012) Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152). Journal of Medicinal Chemistry 55:9, pages 4101-4113.
Crossref
. 2012. Pharmacokinetics and Metabolism in Drug Design. Pharmacokinetics and Metabolism in Drug Design 209 227 .
Stephen Connolly, Marco Skrinjar & Alexander Rosendahl. (2012) Orally bioavailable allosteric CCR8 antagonists inhibit dendritic cell, T cell and eosinophil migration. Biochemical Pharmacology 83:6, pages 778-787.
Crossref
Cierra Hall, Eric Lueshen, Andrej Mošat'Andreas A. Linninger. (2012) Interspecies Scaling in Pharmacokinetics: A Novel Whole-Body Physiologically Based Modeling Framework to Discover Drug Biodistribution Mechanisms in vivo. Journal of Pharmaceutical Sciences 101:3, pages 1221-1241.
Crossref
Alexander V. LyubimovMeihua Rose Feng, Nan Zheng, Xinyuan Zhang, Yea Min Huh & Jing‐yu Yu. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions 1 36 .
Marilyn E. Morris, Xinning Yang, Yash A. Gandhi, Suraj G. Bhansali & Lisa J. Benincosa. (2012) Interspecies scaling: prediction of human biliary clearance and comparison with QSPKR. Biopharmaceutics & Drug Disposition 33:1, pages 1-14.
Crossref
Md Tarique Imam, S. P. Venkateshan, Monika Tandon, Nilanjan Saha & K. K. Pillai. (2011) Comparative Evaluation of US Food and Drug Administration and Pharmacologically Guided Approaches to Determine the Maximum Recommended Starting Dose for First-in-Human Clinical Trials in Adult Healthy Men. The Journal of Clinical Pharmacology 51:12, pages 1655-1664.
Crossref
Hee Eun Kang & Myung Gull Lee. (2011) Approaches for predicting human pharmacokinetics using interspecies pharmacokinetic scaling. Archives of Pharmacal Research 34:11, pages 1779-1788.
Crossref
Lichuan Liu, Jason S. Halladay, Young Shin, Susan Wong, Melis Coraggio, Hank La, Matthew Baumgardner, Hoa Le, Sashi Gopaul, Jason Boggs, Peter Kuebler, John C. DavisJr.Jr., X. Charlene Liao, Joseph W. Lubach, Alan Deese, C. Gregory Sowell, Kevin S. Currie, Wendy B. Young, S. Cyrus Khojasteh, Cornelis E. C. A. Hop & Harvey Wong. (2011) Significant Species Difference in Amide Hydrolysis of GDC-0834, a Novel Potent and Selective Bruton's Tyrosine Kinase Inhibitor. Drug Metabolism and Disposition 39:10, pages 1840-1849.
Crossref
Whitney P. Caron, Harvey Clewell, Robert Dedrick, Ramesh K. Ramanathan, Whitney L. Davis, Ning Yu, Margaret Tonda, Jan H. Schellens, Jos H. Beijnen & William C. Zamboni. (2011) Allometric scaling of pegylated liposomal anticancer drugs. Journal of Pharmacokinetics and Pharmacodynamics 38:5, pages 653-669.
Crossref
Patrick Poulin, Hannah M. Jones, Rhys Do Jones, James W.T. Yates, Christopher R. Gibson, Jenny Y. Chien, Barbara J. Ring, Kimberly K. Adkison, Handan He, Ragini Vuppugalla, Punit Marathe, Volker Fischer, Sandeep Dutta, Vikash K. Sinha, Thorir Björnsson, Thierry Lavé & M. Sherry Ku. (2011) PhRMA CPCDC Initiative on Predictive Models of Human Pharmacokinetics, Part 1: Goals, Properties of the Phrma Dataset, and Comparison with Literature Datasets. Journal of Pharmaceutical Sciences 100:10, pages 4050-4073.
Crossref
Barbara J. Ring, Jenny Y. Chien, Kimberly K. Adkison, Hannah M. Jones, Malcolm Rowland, Rhys Do Jones, James W.T. Yates, M. Sherry Ku, Christopher R. Gibson, Handan He, Ragini Vuppugalla, Punit Marathe, Volker Fischer, Sandeep Dutta, Vikash K. Sinha, Thorir Björnsson, Thierry Lavé & Patrick Poulin. (2011) PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: Comparative assessement of prediction methods of human clearance. Journal of Pharmaceutical Sciences 100:10, pages 4090-4110.
Crossref
David Wexler & Kirk M. Bertelsen. (2013) A Brief Survey of First‐in‐Human Studies. The Journal of Clinical Pharmacology 51:7, pages 988-993.
Crossref
Vikash K. Sinha, Karin Vaarties, Stefan S. De Buck, Luca. A. Fenu, Marjoleen Nijsen, Ron A.H.J. Gilissen, Wendy Sanderson, Kelly Van Uytsel, Eva Hoeben, Achiel Van Peer, Claire E. Mackie & Johan W. Smit. (2011) Towards a Better Prediction of Peak Concentration, Volume of Distribution and Half-Life after Oral Drug Administration in Man, Using Allometry. Clinical Pharmacokinetics 50:5, pages 307-318.
Crossref
Iftekhar Mahmood. (1998) Interspecies Scaling: Predicting Volumes, Mean Residence Time and Elimination Half-life. Some Suggestions. Journal of Pharmacy and Pharmacology 50:5, pages 493-499.
Crossref
Chao Han & Honghui Zhou. (2011) Monoclonal antibodies: interspecies scaling with minimal preclinical information. Therapeutic Delivery 2:3, pages 359-368.
Crossref
Sekihiro Tamaki, Hiroshi Komura, Motohiro Kogayu & Shizuo Yamada. (2011) Comparative Assessment of Empirical and Physiological Approaches on Predicting Human Clearances. Journal of Pharmaceutical Sciences 100:3, pages 1147-1155.
Crossref
Tobias Pähler & Jochen Maas. 2011. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology 9 13 .
Peter L. BonatePeter L. Bonate. 2011. Pharmacokinetic-Pharmacodynamic Modeling and Simulation. Pharmacokinetic-Pharmacodynamic Modeling and Simulation 157 187 .
Zvi Teitelbaum, Thierry Lave, Jan Freijer & Adam F. Cohen. (2010) Risk Assessment in Extrapolation of Pharmacokinetics from Preclinical Data to Humans. Clinical Pharmacokinetics 49:9, pages 619-632.
Crossref
Melvin J. Yu. (2010) Predicting Total Clearance in Humans from Chemical Structure. Journal of Chemical Information and Modeling 50:7, pages 1284-1295.
Crossref
James W. Paxton. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia 1 22 .
William L. Hayton & Teh‐Min Hu. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia 1 28 .
Kosalaram Goteti, C.Edwin Garner & Iftekhar Mahmood. (2010) Prediction of Human Drug Clearance from Two Species: A Comparison of Several Allometric Methods. Journal of Pharmaceutical Sciences 99:3, pages 1601-1613.
Crossref
Urban Fagerholm. (2007) Prediction of human pharmacokinetics—evaluation of methods for prediction of hepatic metabolic clearance. Journal of Pharmacy and Pharmacology 59:6, pages 803-828.
Crossref
Iftekhar Mahmood. (1999) Prediction of Clearance, Volume of Distribution and Half-life by Allometric Scaling and by use of Plasma Concentrations Predicted from Pharmacokinetic Constants: a Comparative Study. Journal of Pharmacy and Pharmacology 51:8, pages 905-910.
Crossref
Toshihiro Wajima, Kazuya Fukumura, Yoshitaka Yano & Takayoshi Oguma. (2003) Prediction of human pharmacokinetics from animal data and molecular structural parameters using multivariate regression analysis: volume of distribution at steady state. Journal of Pharmacy and Pharmacology 55:7, pages 939-949.
Crossref
Sven Björkman & Finn Redke. (2000) Clearance of Fentanyl, Alfentanil, Methohexitone, Thiopentone and Ketamine in Relation to Estimated Hepatic Blood Flow in Several Animal Species: Application to Prediction of Clearance in Man. Journal of Pharmacy and Pharmacology 52:9, pages 1065-1074.
Crossref
Hua Yang, Xingrong Liu, Anjaneya Chimalakonda, Zheng Lu, Cuiping Chen, Frank Lee & Wen Chyi Shyu. 2009. Enzyme Inhibition in Drug Discovery and Development. Enzyme Inhibition in Drug Discovery and Development 177 239 .
Jie Ling, Honghui Zhou, Qun Jiao & Hugh M. Davis. (2013) Interspecies Scaling of Therapeutic Monoclonal Antibodies: Initial Look. The Journal of Clinical Pharmacology 49:12, pages 1382-1402.
Crossref
Cristiano Migliorini, Thierry Lave, Neil J. Parrott, Micaela Reddy, Hans Peter Grimm, Robert C. Penland, Antoine Soubret, Gabriel Helmlinger, Anna Georgieva & Klaas P. Zuideveld. 2009. General, Applied and Systems Toxicology. General, Applied and Systems Toxicology.
M. MARTINEZ, I. MAHMOOD & R. P. HUNTER. (2009) Allometric scaling of clearance in dogs. Journal of Veterinary Pharmacology and Therapeutics 32:5, pages 411-416.
Crossref
Iftekhar Mahmood. (2009) Pharmacokinetic Allometric Scaling of Antibodies: Application to the First-In-Human Dose Estimation. Journal of Pharmaceutical Sciences 98:10, pages 3850-3861.
Crossref
Iftekhar Mahmood. (2009) Role of Fixed Coefficients and Exponents in the Prediction of Human Drug Clearance: How Accurate are the Predictions from One or Two Species?. Journal of Pharmaceutical Sciences 98:7, pages 2472-2493.
Crossref
Aberra Fura, Ashish Khanna, Viral Vyas, Barry Koplowitz, Shu-Ying Chang, Christian Caporuscio, David W. Boulton, Lisa J. Christopher, Kristina D. Chadwick, Lawrence G. Hamann, W. Griffith Humphreys & Mark Kirby. (2009) Pharmacokinetics of the Dipeptidyl Peptidase 4 Inhibitor Saxagliptin in Rats, Dogs, and Monkeys and Clinical Projections. Drug Metabolism and Disposition 37:6, pages 1164-1171.
Crossref
Natilie A. Hosea, Wendy T. Collard, Susan Cole, Tristan S. Maurer, Rick X. Fang, Hannah Jones, Shefali M. Kakar, Yasuhiro Nakai, Bill J. Smith, Rob Webster & Kevin Beaumont. (2009) Prediction of Human Pharmacokinetics From Preclinical Information: Comparative Accuracy of Quantitative Prediction Approaches. The Journal of Clinical Pharmacology 49:5, pages 513-533.
Crossref
Hye Young Ji, Beom Soo Shin, Dong Won Jeong, Eun Jeong Park, Eun-Seok Park, Sun Dong Yoo & Hye Suk Lee. (2009) Interspecies scaling of oleanolic acid in mice, rats, rabbits and dogs and prediction of human pharmacokinetics. Archives of Pharmacal Research 32:2, pages 251-257.
Crossref
I. Mahmood. (2009) Application of Fixed Exponent 0.75 to the Prediction of Human Drug Clearance: An Inaccurate and Misleading Concept. Drug Metabolism and Drug Interactions 24:1, pages 57-82.
Crossref
Aberra Fura, Viral Vyas, William Humphreys, Anjaneya Chimalokonda & David Rodrigues. (2008) Prediction of human oral pharmacokinetics using nonclinical data: examples involving four proprietary compounds. Biopharmaceutics & Drug Disposition 29:8, pages 455-468.
Crossref
Chandra Prakash & Alfin D. N. Vaz. 2008. Nuclear Receptors in Drug Metabolism. Nuclear Receptors in Drug Metabolism 1 41 .
Kosalaram Goteti, Patrick J. Brassil, Steven S. Good & C. Edwin Garner. (2008) Estimation of Human Drug Clearance Using Multiexponential Techniques. The Journal of Clinical Pharmacology 48:10, pages 1226-1236.
Crossref
R. E. Nordquist, T. Steckler, J. G. Wettstein, C. Mackie & W. Spooren. (2008) Metabotropic glutamate receptor modulation, translational methods, and biomarkers: relationships with anxiety. Psychopharmacology 199:3, pages 389-402.
Crossref
Christine Huang, Ming Zheng, Zheng Yang, A. David Rodrigues & Punit Marathe. (2007) Projection of Exposure and Efficacious Dose Prior to First-in-Human Studies: How Successful Have We Been?. Pharmaceutical Research 25:4, pages 713-726.
Crossref
Vikash K Sinha, Stefan S De Buck, Luca A Fenu, Johan W Smit, Marjoleen Nijsen, Ron A H J Gilissen, Achiel Van Peer, Karel Lavrijsen & Claire E Mackie. (2008) Predicting Oral Clearance in Humans. Clinical Pharmacokinetics 47:1, pages 35-45.
Crossref
Punit H. Marathe, Christine Huang & A. David Rodrigues. 2008. 311 328 .
Huadong Tang & Michael Mayersohn. (2007) Utility of the Coefficient of Determination ( r 2 ) in Assessing the Accuracy of Interspecies Allometric Predictions: Illumination or Illusion? . Drug Metabolism and Disposition 35:12, pages 2139-2142.
Crossref
Huadong Tang, Azher Hussain, Mauricio Leal, Michael Mayersohn & Eric Fluhler. (2007) Interspecies Prediction of Human Drug Clearance Based on Scaling Data from One or Two Animal Species. Drug Metabolism and Disposition 35:10, pages 1886-1893.
Crossref
ROBERT L. DEDRICK & ARTHUR J. ATKINSONJr.Jr.. 2007. Principles of Clinical Pharmacology. Principles of Clinical Pharmacology 463 471 .
T. Laveé, N. Parrott & H. Jones. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II 867 884 .
Hong Xiang, Jeanelle McSurdy-Freed, Ganesh S. Moorthy, Erin Hugger, Ramesh Bambal, Chao Han, Santiago Ferrer, Domingo Gargallo & Charles B. Davis. (2006) Preclinical Drug Metabolism and Pharmacokinetic Evaluation of GW844520, A Novel Anti-Malarial Mitochondrial Electron Transport Inhibitor. Journal of Pharmaceutical Sciences 95:12, pages 2657-2672.
Crossref
Amit S. Kalgutkar, Heather L. Hatch, Frederick Kosea, Hang T. Nguyen, Edna F. Choo, Kim F. McClure, Timothy J. Taylor, Kirk R. Henne, Alexander V. Kuperman, Mark A. Dombroski & Michael A. Letavic. (2006) Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38α inhibitor: identification of an active metabolite in preclinical species and human liver microsomes. Biopharmaceutics & Drug Disposition 27:8, pages 371-386.
Crossref
M. MARTINEZ, I. MAHMOOD & R. P. HUNTER. (2006) Interspecies allometric scaling: prediction of clearance in large animal species: Part II: mathematical considerations. Journal of Veterinary Pharmacology and Therapeutics 29:5, pages 425-432.
Crossref
I. MAHMOOD, M. MARTINEZ & R. P. HUNTER. (2006) Interspecies allometric scaling. Part I: prediction of clearance in large animals. Journal of Veterinary Pharmacology and Therapeutics 29:5, pages 415-423.
Crossref
Huadong Tang & Michael Mayersohn. (2006) A global examination of allometric scaling for predicting human drug clearance and the prediction of large vertical allometry**This work was presented at the American Association of Pharmaceutical Scientists Annual meeting, Salt Lake City, USA, Oct. 26, 2003.. Journal of Pharmaceutical Sciences 95:8, pages 1783-1799.
Crossref
Christopher A. Evans, Larry J. Jolivette, Rakesh Nagilla & Keith W. Ward. (2006) EXTRAPOLATION OF PRECLINICAL PHARMACOKINETICS AND MOLECULAR FEATURE ANALYSIS OF “DISCOVERY-LIKE” MOLECULES TO PREDICT HUMAN PHARMACOKINETICS. Drug Metabolism and Disposition 34:7, pages 1255-1265.
Crossref
Tomoe Fujita, Yoshiaki Matsumoto, Machiko Ozaki, Masataka Majima, Yuji Kumagai & Yoshio Ohtani. (2013) Comparison of Maximum Drug Concentration and Area Under the Time‐Concentration Curve Between Humans and Animals for Oral and Intravenous Investigational Drugs. The Journal of Clinical Pharmacology 46:6, pages 674-692.
Crossref
Lucy Lee, Sunil Sharma, Bruno Morgan, Peter Allegrini, Christian Schnell, Josef Brueggen, Robert Cozens, Mark Horsfield, Clemens Guenther, Will P. Steward, Joachim Drevs, David Lebwohl, Jeanette Wood & Paul M. J. McSheehy. (2005) Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases. Cancer Chemotherapy and Pharmacology 57:6, pages 761-771.
Crossref
Paolo Vicini. 2006. Encyclopedia of Medical Devices and Instrumentation. Encyclopedia of Medical Devices and Instrumentation.
Huadong Tang & Michael Mayersohn. (2006) On the Observed Large Interspecies Overprediction of Human Clearance (“Vertical Allometry”) of UCN-01: Further Support for a Proposed Model Based on Plasma Protein Binding. The Journal of Clinical Pharmacology 46:4, pages 398-400.
Crossref
Huadong Tang & Michael Mayersohn. (2006) RESPONSE TO COMMENTS ON “A MATHEMATICAL DESCRIPTION OF THE FUNCTIONALITY OF CORRECTION FACTORS USED IN ALLOMETRY FOR PREDICTING HUMAN DRUG CLEARANCE”. Drug Metabolism and Disposition 34:3, pages 510-511.
Crossref
Iftekhar Mahmood. (2006) COMMENTS ON “A MATHEMATICAL DESCRIPTION OF THE FUNCTIONALITY OF CORRECTION FACTORS USED IN ALLOMETRY FOR PREDICTING HUMAN DRUG CLEARANCE”: TABLE 1. Drug Metabolism and Disposition 34:3, pages 507-509.
Crossref
Anne Paccaly, Annke Frick, Shashank Rohatagi, Jingli Liu, Umesh Shukla, Ronald Rosenburg, Markus Hinder & Bradford K. Jensen. (2006) Pharmacokinetics of Otamixaban, a Direct Factor Xa Inhibitor, in Healthy Male Subjects: Pharmacokinetic Model Development for Phase 2/3 Simulation of Exposure. The Journal of Clinical Pharmacology 46:1, pages 37-44.
Crossref
JOERG MAYER, GRETCHEN KAUFMAN & MARK POKRAS. 2006. Reptile Medicine and Surgery. Reptile Medicine and Surgery 419 427 .
Huadong Tang & Michael Mayersohn. (2005) A NOVEL MODEL FOR PREDICTION OF HUMAN DRUG CLEARANCE BY ALLOMETRIC SCALING. Drug Metabolism and Disposition 33:9, pages 1297-1303.
Crossref
Huadong Tang & Michael Mayersohn. (2005) A MATHEMATICAL DESCRIPTION OF THE FUNCTIONALITY OF CORRECTION FACTORS USED IN ALLOMETRY FOR PREDICTING HUMAN DRUG CLEARANCE. Drug Metabolism and Disposition 33:9, pages 1294-1296.
Crossref
Huadong Tang & Michael Mayersohn. (2005) ACCURACY OF ALLOMETRICALLY PREDICTED PHARMACOKINETIC PARAMETERS IN HUMANS: ROLE OF SPECIES SELECTION. Drug Metabolism and Disposition 33:9, pages 1288-1293.
Crossref
Rakesh Nagilla & Keith W. Ward. (2005) Correspondence. Journal of Pharmaceutical Sciences 94:5, pages 946-947.
Crossref
Iftekhar Mahmood. (2005) The Correction Factors Do Help in Improving the Prediction of Human Clearance from Animal Data. Journal of Pharmaceutical Sciences 94:5, pages 940-945.
Crossref
Koen Jolling, Juan Jose Perez Ruixo, Alex Hemeryck, An Vermeulen & Tony Greway. (2005) Mixed-effects modelling of the interspecies pharmacokinetic scaling of pegylated human erythropoietin. European Journal of Pharmaceutical Sciences 24:5, pages 465-475.
Crossref
Iftekhar Mahmood. (2005) Interspecies Scaling of Biliary Excreted Drugs: A Comparison of Several Methods**The views expressed in this article are those of the author and do not reflect the official policy of the FDA. No official support or endorsement by the FDA is intended or should be inferred.. Journal of Pharmaceutical Sciences 94:4, pages 883-892.
Crossref
Kiyomi Ito & J. Brian Houston. (2005) Prediction of Human Drug Clearance from in Vitro and Preclinical Data Using Physiologically Based and Empirical Approaches. Pharmaceutical Research 22:1, pages 103-112.
Crossref
Jörg Keldenich. (2004) Prediction of human clearance (CL) and volume of distribution (VD). Drug Discovery Today: Technologies 1:4, pages 389-395.
Crossref
Rakesh Nagilla & Keith W. Ward. (2004) A comprehensive analysis of the role of correction factors in the allometric predictivity of clearance from rat, dog, and monkey to humans. Journal of Pharmaceutical Sciences 93:10, pages 2522-2534.
Crossref
Keith W. Ward & Brian R. Smith. (2004) A COMPREHENSIVE QUANTITATIVE AND QUALITATIVE EVALUATION OF EXTRAPOLATION OF INTRAVENOUS PHARMACOKINETIC PARAMETERS FROM RAT, DOG, AND MONKEY TO HUMANS. I. CLEARANCE. Drug Metabolism and Disposition 32:6, pages 603-611.
Crossref
K. Schneider, J. Oltmanns & M. Hassauer. (2004) Allometric principles for interspecies extrapolation in toxicological risk assessment—empirical investigations. Regulatory Toxicology and Pharmacology 39:3, pages 334-347.
Crossref
Iftekhar Mahmood. 2004. New Drug Development. New Drug Development 137 163 .
Jorge Ducongé, Eduardo Fernández‐Sánchez & Daniel Alvarez. (2004) Interspecies scaling of the monoclonal anti‐EGF receptor ior EGF/r3 antibody disposition using allometric paradigm: is it really suitable?. Biopharmaceutics & Drug Disposition 25:4, pages 177-186.
Crossref
Thierry Lavé, Olivier Luttringer, Patrick Poulin & Neil Parrott. 2004. Applications of Pharmacokinetic Principles in Drug Development. Applications of Pharmacokinetic Principles in Drug Development 133 175 .
Iftekhar Mahmood. (2004) Interspecies Scaling of Protein Drugs: Prediction of Clearance from Animals to Humans. Journal of Pharmaceutical Sciences 93:1, pages 177-185.
Crossref
Toshihiro Wajima, Kazuya Fukumura, Yoshitaka Yano & Takayoshi Oguma. (2003) Prediction of Human Pharmacokinetics from Animal Data and Molecular Structural Parameters using Multivariate Regression Analysis: Oral Clearance. Journal of Pharmaceutical Sciences 92:12, pages 2427-2440.
Crossref
Hiroyoshi Hayakawa, Yoko Fukushima, Hiroshi Kato, Hiroyuki Fukumoto, Takumi Kadota, Hiroyuki Yamamoto, Hiroyuki Kuroiwa, Junko Nishigaki & Akira Tsuji. (2003) METABOLISM AND DISPOSITION OF NOVEL DES-FLUORO QUINOLONE GARENOXACIN IN EXPERIMENTAL ANIMALS AND AN INTERSPECIES SCALING OF PHARMACOKINETIC PARAMETERS. Drug Metabolism and Disposition 31:11, pages 1409-1418.
Crossref
Iftekhar Mahmood, Martin David Green & J. Edward Fisher. (2003) Selection of the First-Time Dose in Humans: Comparison of Different Approaches Based on Interspecies Scaling of Clearance. The Journal of Clinical Pharmacology 43:7, pages 692-697.
Crossref
O. Østerberg, B. Kiehr, L. Erichsen, H.E. Poulsen & S.H. Ingwersen. (2003) Pharmacokinetics and allometric scaling of levormeloxifene, a selective oestrogen receptor modulator. Biopharmaceutics & Drug Disposition 24:3, pages 121-129.
Crossref
István Hermecz. 2003. 219 353 .
Toshihiro Wajima, Kazuya Fukumura, Yoshitaka Yano & Takayoshi Oguma. (2002) Prediction of Human Clearance from Animal Data and Molecular Structural Parameters using Multivariate Regression Analysis. Journal of Pharmaceutical Sciences 91:12, pages 2489-2499.
Crossref
Iftekhar Mahmood & Chandra Sahajwalla. (2002) Interspecies scaling of biliary excreted drugs. Journal of Pharmaceutical Sciences 91:8, pages 1908-1914.
Crossref
Brian J. Anderson & George H. Meakin. (2002) Scaling for size: some implications for paediatric anaesthesia dosing. Pediatric Anesthesia 12:3, pages 205-219.
Crossref
I. Mahmood. (2002) Prediction of Clearance in Humans from In Vitro Human Liver Microsomes and Allometric Scaling. A Comparative Study of the Two Approaches. Drug Metabolism and Drug Interactions 19:1.
Crossref
Iftekhar Mahmood. (2002) Interspecies Scaling: Predicting Oral Clearance in Humans. American Journal of Therapeutics 9:1, pages 35-42.
Crossref
. 2002. Handbook of Essential Pharmacokinetics, Pharmacodynamics and Drug Metabolism for Industrial Scientists. Handbook of Essential Pharmacokinetics, Pharmacodynamics and Drug Metabolism for Industrial Scientists 207 228 .
Teh-Min Hu & William L. Hayton. (2015) Allometric scaling of xenobiotic clearance: Uncertainty versus universality. AAPS PharmSci 3:4, pages 30-43.
Crossref
Paul Morgan. (2001) The use of preclinical pharmacokinetic and pharmacodynamic data to predict clinical doses: current and future perspectives. International Congress Series 1220, pages 1-12.
Crossref
Iftekhar Mahmood. (2001) Interspecies Scaling of Maximum Tolerated Dose of Anticancer Drugs: Relevance to Starting Dose for Phase I Clinical Trials. American Journal of Therapeutics 8:2, pages 109-116.
Crossref
I. Mahmood. (2001) Interspecies Scaling: Is a priori Knowledge of Cytochrome P450 Isozymes Involved in Drug Metabolism Helpful in Prediction of Clearance in Humans from Animal Data?. Drug Metabolism and Drug Interactions 18:2.
Crossref
Iftekhar Mahmood. (2001) Application of Preclinical Data to Initiate the Modified Continual Reassessment Method for Maximum Tolerated Dose-Finding Trials. The Journal of Clinical Pharmacology 41:1, pages 19-24.
Crossref
Iftekhar Mahmood. (2013) Interspecies Scaling: Role of Protein Binding in the Prediction of Clearance from Animals to Humans. The Journal of Clinical Pharmacology 40:12, pages 1439-1446.
Crossref

Displaying 200 of 209 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.